Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is rated as a Distinguished provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy.

Dr. Janet L. Crane is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. Dr. Crane is the Director of the Pediatric Bone Health Program, which focuses on the care of children with rare metabolic bone diseases and osteoporosis/skeletal fragility syndromes. Dr. Crane received her bachelor’s degree in nutritional science from the University of Missouri. She completed her medical degree at the University of Maryland-Baltimore, residency in pediatrics at Children's Mercy Hospital and Clinics in Kansas City, Missouri and fellowship in pediatric endocrinology at Johns Hopkins University in 2013. Dr. Crane is a faculty member of the Center for Musculoskeletal Research. Her research is focused on bone modeling and remodeling factors that result in proper bone growth and strength. The goal of her studies is to identify diagnostic markers and therapeutic targets to enhance bone strength in children who have recurrent fractures. Dr. Crane also participates in industry sponosored clinical studies to investigate the safety and efficacy of medications for metabolic bone disease and skeletal fragility. Dr. Crane is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteogenesis Imperfecta, Juvenile Primary Osteoporosis, Short Stature (Growth Disorders), and Noonan Syndrome.

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. David Valle is a professor of pediatrics and ophthalmology at the Johns Hopkins School of Medicine and former director of the Johns Hopkins Department of Genetic Medicine. He also serves as a geneticist for the Johns Hopkins Children’s Center. Dr. Valle holds a bachelor’s degree and medical degree from Duke University. He completed a pediatric residency at Johns Hopkins University before joining the Johns Hopkins faculty. He is interested in the genetic contributions to health and disease. He is the founding director of the Johns Hopkins Center for Inherited Disease Research. Over the years, his laboratory has discovered the genetic causation for more than 20 diseases, including those responsible for inborn errors of metabolism, inherited retinal degeneration, disorders of cellular organelle biogenesis and genetic variations that contribute risk for common disorders such as schizophrenia. Dr. Valle also serves as director of the Predoctoral Training Program in Human Genetics, as well as co-director of the Genes to Society program. He was a 2014 recipient of the annual Victor A. McKusick Leadership Award from the American Society of Human Genetics, which recognizes individuals whose professional achievements have fostered and enriched the development of human genetics as well as its assimilation into the broader context of science, medicine and health. Dr. Valle is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Spondyloepimetaphyseal Dysplasia Strudwick Type, Micrognathia, Urea Cycle Disorders (UCD), and Spondyloepiphyseal Dysplasia Congenita.

Dr. Mohamad Hanouneh is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Hanouneh grew up in Syria and completed his medical school in Tishreen University in Latakia, Syria. He completed Internal Medicine Residency training at Cleveland Clinic, and Nephrology Fellowship at Johns Hopkins. Dr. Hanouneh currently serves as a part-time faculty in the Division of Nephrology at Johns Hopkins. He also works in the Nephrology Center of Maryland covering Good Samaritan and Upper Chesapeake Hospitals. Dr. Hanouneh has a passion in medical education. He runs the nephrology board review course and participates in Genes to Society Course of Renal Physiology, which is given to the medical students at Johns Hopkins University School of Medicine. His area of interests are electrolytes disorders, diabetic kidney disease and nephrolithiasis. Dr. Hanouneh is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Low Potassium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and High Potassium Level.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Farah Abifaraj is a Nephrologist in Baltimore, Maryland. Dr. Abifaraj is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), High Potassium Level, and Hypophosphatasia (HPP).

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Low Potassium Level, and Kidney Transplant.

Anita Pasumarthy is a Nephrologist in Baltimore, Maryland. Dr. Pasumarthy is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

Anju Yadav is a Nephrologist and a Transplant Surgeon in Baltimore, Maryland. Dr. Yadav is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD).

Sarah Khan is a Nephrologist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Autosomal Dominant Hypocalcemia, Nephrosclerosis, Renovascular Hypertension, and Hypophosphatemia. Dr. Khan is currently accepting new patients.

Preeti Chandra is a Nephrologist in Baltimore, Maryland. Dr. Chandra is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Acute Kidney Failure, Lupus Nephritis, IgA Nephropathy, and Thin Basement Membrane Nephropathy. Dr. Chandra is currently accepting new patients.

Ujwal Gautam is a Nephrologist in Baltimore, Maryland. Dr. Gautam is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Hypophosphatemia, Childhood Hypophosphatasia (HPP), Hypophosphatasia (HPP), and Juvenile Paget's Disease. Dr. Gautam is currently accepting new patients.

Valeriu Cebotaru is a Nephrologist in Baltimore, Maryland. Dr. Cebotaru is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis. Dr. Cebotaru is currently accepting new patients.

Abdolreza Haririan is a Nephrologist in Baltimore, Maryland. Dr. Haririan is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Cytomegalovirus Infection, Chronic Kidney Disease, Cytomegalic Inclusion Disease, Acute Kidney Failure, and Kidney Transplant. Dr. Haririan is currently accepting new patients.

Hiba Ahmed is a Nephrologist in Baltimore, Maryland. Dr. Ahmed is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Hypophosphatemia, and Juvenile Paget's Disease. Dr. Ahmed is currently accepting new patients.

Richard Ugarte is a Nephrologist in Baltimore, Maryland. Dr. Ugarte is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Acute Kidney Failure, Nephrosclerosis, and Kidney Transplant. Dr. Ugarte is currently accepting new patients.

Tihana Premuzic is a Nephrologist in Baltimore, Maryland. Dr. Premuzic is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Autosomal Dominant Hypocalcemia, Hypophosphatemia, Childhood Hypophosphatasia (HPP), and Hypophosphatasia (HPP). Dr. Premuzic is currently accepting new patients.

Ami Patel is a Nephrologist in Baltimore, Maryland. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Hypophosphatasia (HPP). Her top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, and End-Stage Renal Disease (ESRD). Dr. Patel is currently accepting new patients.